Insider Transactions in Q1 2022 at Oyster Point Pharma, Inc. (OYST)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2022
|
Daniel Lochner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
938
-1.21%
|
$10,318
$11.7 P/Share
|
|
Jan 29
2022
|
Jeffrey Nau President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,607
-1.72%
|
$28,677
$11.7 P/Share
|
|
Jan 09
2022
|
Daniel Lochner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+20.06%
|
-
|
|
Jan 09
2022
|
Jeffrey Nau President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
46,700
+22.86%
|
-
|
|
Jan 09
2022
|
John Snisarenko Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,100
+28.52%
|
-
|
|
Jan 05
2022
|
Clare Ozawa Director |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-55.47%
|
-
|
|
Jan 05
2022
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Direct |
120
+1.07%
|
-
|
|
Jan 05
2022
|
Clare Ozawa Director |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Jan 05
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
253,030
-55.47%
|
-
|
|
Jan 05
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
51,556
+50.0%
|
-
|
|
Jan 05
2022
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
6,839
+16.17%
|
-
|